EE239 How to Consider Caregiver Health-Related Quality of Life in a Cost-Effectiveness Analysis? An Illustration with Dupilumab for the Treatment of Severe Atopic Dermatitis in Infants in France
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.507
https://www.valueinhealthjournal.com/article/S1098-3015(23)03637-9/fulltext
Title :
EE239 How to Consider Caregiver Health-Related Quality of Life in a Cost-Effectiveness Analysis? An Illustration with Dupilumab for the Treatment of Severe Atopic Dermatitis in Infants in France
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03637-9&doi=10.1016/j.jval.2023.09.507
First page :
Section Title :
Open access? :
No
Section Order :
12532